IL180741A0 - Stable injectable composition of alpha tocopheryl succcinate, analogues and salts thereof - Google Patents

Stable injectable composition of alpha tocopheryl succcinate, analogues and salts thereof

Info

Publication number
IL180741A0
IL180741A0 IL180741A IL18074107A IL180741A0 IL 180741 A0 IL180741 A0 IL 180741A0 IL 180741 A IL180741 A IL 180741A IL 18074107 A IL18074107 A IL 18074107A IL 180741 A0 IL180741 A0 IL 180741A0
Authority
IL
Israel
Prior art keywords
succcinate
analogues
salts
injectable composition
alpha tocopheryl
Prior art date
Application number
IL180741A
Other languages
English (en)
Original Assignee
Sd Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sd Pharmaceuticals Inc filed Critical Sd Pharmaceuticals Inc
Publication of IL180741A0 publication Critical patent/IL180741A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL180741A 2004-07-28 2007-01-16 Stable injectable composition of alpha tocopheryl succcinate, analogues and salts thereof IL180741A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59209704P 2004-07-28 2004-07-28
PCT/US2005/026783 WO2006015120A2 (en) 2004-07-28 2005-07-28 Stable injectable composition of alpha tocopheryl succinate, analogues and salts thereof

Publications (1)

Publication Number Publication Date
IL180741A0 true IL180741A0 (en) 2007-07-04

Family

ID=35787824

Family Applications (1)

Application Number Title Priority Date Filing Date
IL180741A IL180741A0 (en) 2004-07-28 2007-01-16 Stable injectable composition of alpha tocopheryl succcinate, analogues and salts thereof

Country Status (11)

Country Link
US (1) US20060024360A1 (https=)
EP (1) EP1778217A4 (https=)
JP (1) JP2008508302A (https=)
KR (1) KR20070059072A (https=)
CN (1) CN1925853B (https=)
AU (1) AU2005269383A1 (https=)
CA (1) CA2575216A1 (https=)
IL (1) IL180741A0 (https=)
NO (1) NO20070983L (https=)
RU (1) RU2007107359A (https=)
WO (1) WO2006015120A2 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
US8557861B2 (en) 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20080038316A1 (en) * 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
CN101011355B (zh) * 2006-02-01 2013-01-02 陈献 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
US20080045589A1 (en) * 2006-05-26 2008-02-21 Susan Kelley Drug Combinations with Substituted Diaryl Ureas for the Treatment of Cancer
NZ575920A (en) 2006-09-15 2012-08-31 Stephen John Ralph Pro-oxidant anti-cancer compounds
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
CA2686225A1 (en) * 2007-06-22 2008-12-31 Scidose Llc Solubilized formulation of docetaxel without tween 80
NZ602579A (en) 2008-03-14 2013-12-20 Stephen John Ralph Mitochondrially delivered anti-cancer compounds
US20100260830A1 (en) * 2009-04-08 2010-10-14 Brian A Salvatore Liposomal Formulations of Tocopheryl Amides
WO2011004552A1 (ja) * 2009-07-09 2011-01-13 国立大学法人九州大学 水溶性薬物キャリア及びその製造方法
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
WO2011025771A1 (en) * 2009-08-25 2011-03-03 Biogen Idec Ma Inc. Compositions for delivery of insoluble agents
US8912228B2 (en) 2009-10-19 2014-12-16 Scidose Llc Docetaxel formulations with lipoic acid
US20110092579A1 (en) * 2009-10-19 2011-04-21 Scidose Llc Solubilized formulation of docetaxel
US7772274B1 (en) 2009-10-19 2010-08-10 Scidose, Llc Docetaxel formulations with lipoic acid
US8476310B2 (en) 2009-10-19 2013-07-02 Scidose Llc Docetaxel formulations with lipoic acid
US8541465B2 (en) * 2009-10-19 2013-09-24 Scidose, Llc Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
UA110383C2 (en) 2011-06-08 2015-12-25 Akzo Nobel Chemicals Int Bv Deicing composition
EA027593B1 (ru) 2011-06-08 2017-08-31 Акцо Нобель Кемикалз Интернэшнл Б.В. Противогололедная композиция
AR088524A1 (es) 2011-11-09 2014-06-18 Akzo Nobel Chemicals Int Bv Composicion descongelante, proceso de preparacion, conjunto de parte y uso
EP2846773A4 (en) 2012-05-10 2015-12-30 Painreform Ltd DEPOT FORMULATIONS OF A LOCAL ANESTHETICS AND METHOD FOR THE MANUFACTURE THEREOF
JP6094388B2 (ja) * 2013-06-07 2017-03-15 ニプロ株式会社 ペメトレキセドを含む注射用組成物
JP6087769B2 (ja) * 2013-08-30 2017-03-01 サントリー食品インターナショナル株式会社 烏龍茶抽出物を含有する容器詰飲料
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods
WO2017120586A1 (en) * 2016-01-07 2017-07-13 Western University Of Health Sciences Formulations for treating bladder cancer
KR101978108B1 (ko) * 2017-07-20 2019-05-13 데루타-후라이 화마 가부시키가이샤 암 세포의 대사 특이성에 기초하는 신규 항 악성 종양제
US12453805B2 (en) 2020-09-24 2025-10-28 Everest Medical Innovation GmbH Cryoprotective compositions, surgical kits, and methods for protection of a surgical site during cryosurgery
US12426594B2 (en) 2020-09-24 2025-09-30 Everest Medical Innovation GmbH Cryoprotective compositions and methods for protection of a surgical site during cryosurgery
CN120365238A (zh) * 2025-05-29 2025-07-25 无锡知妍生物科技有限公司 单生育酚壬二酸酯及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3173838A (en) * 1962-03-28 1965-03-16 Eastman Kodak Co Solid, vitamin e-active product and process for making it
US4783220A (en) * 1986-12-18 1988-11-08 Xerox Corporation Vesicle ink compositions
CA2130357A1 (en) * 1992-02-18 1993-08-19 Doron Friedman Dry compositions for preparing submicron emulsions
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6727280B2 (en) * 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030005407A1 (en) * 2000-06-23 2003-01-02 Hines Kenneth J. System and method for coordination-centric design of software systems
US20030099674A1 (en) * 2001-08-11 2003-05-29 Chen Andrew X. Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
US20040175415A1 (en) * 2003-03-05 2004-09-09 Chan Alvin C. Formulations and methods of delivery of intact tocopheryl succinate to humans
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs

Also Published As

Publication number Publication date
WO2006015120A3 (en) 2006-05-18
JP2008508302A (ja) 2008-03-21
EP1778217A4 (en) 2008-10-08
EP1778217A2 (en) 2007-05-02
KR20070059072A (ko) 2007-06-11
RU2007107359A (ru) 2008-09-10
CN1925853B (zh) 2011-01-26
AU2005269383A1 (en) 2006-02-09
CN1925853A (zh) 2007-03-07
CA2575216A1 (en) 2006-02-09
WO2006015120A2 (en) 2006-02-09
US20060024360A1 (en) 2006-02-02
NO20070983L (no) 2007-02-27

Similar Documents

Publication Publication Date Title
IL180741A0 (en) Stable injectable composition of alpha tocopheryl succcinate, analogues and salts thereof
IL181301A0 (en) Cyclopamine analogues, pharmaceutical compositions comprising them and uses thereof
AP2006003768A0 (en) TetraazabenzoÄeÜazulene derivatives and analogs tehereof
IL181235A0 (en) Substituted phenylacetamides and their use as glucokinase activators
DK1819670T3 (da) 12-Aryl-prostaglandinanaloger
PL372814A1 (en) Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
EP1762234A4 (en) AMPK AKTIVATOR
MA28841B1 (fr) Analogues tetrapeptidiques
IL185292A0 (en) Nanoparticulate formulations of docetaxel and analogues thereof
BRPI0717695A2 (pt) "composição, uso de uma compsição e processo de preparação de uma composição"
ZA200700709B (en) Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
IL211936A0 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
IL184266A0 (en) 2,5 and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
IL179627A0 (en) Particulate-stabilized injectable pharmaceutical compositions of posaconasole
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
IL176922A0 (en) Compositions and methods of use of a-type procyanidins
IL178461A0 (en) Substituted 4-alkyl -and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
ZA200606606B (en) Substituted Azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
BRPI0611025A2 (pt) composto, uso de um composto, e, composição farmacêuticamente aceitável
EP1720542A4 (en) ARYL ALKYLAMINO-SUBSTITUTED CHINAZOLINE ANALOGUE
EP1773741A4 (en) SYNTHESIS OF (-) - BETA-ELEMENES, (-) - BETA-ELEMENAL, (-) - BETA-ELEMENOL, (-) - BETA-ELEMEN FLUORIDE AND ANALOGUE, INTERMEDIATE PRODUCTS AND COMPOSITIONS AND THEIR APPLICATIONS
PT1830885E (pt) Composição veterinária injectável
BRPI0611748A2 (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
EP1817266A4 (en) PREMIXED CEMENT MASSES CONTAINING NON-CHLORIDE ACCELERATORS
EP1824490A4 (en) PIPERAZINYL-PYRIDINE ANALOGS